Sales & Marketing News | pharmaphorum

News

A rendering of AstraZeneca's manufacturing facility in Virginia

AZ starts work on Virginia plant in $50bn US investment plan

The first stage of AstraZeneca's promised $50 billion investment in US facilities is underway as it breaks ground on a facility in Virginia.

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

News

Image of J&J baby powder as originally sold

J&J on the hook for $966m damages in latest talc lawsuit

Johnson & Johnson has suffered a setback in its long-running legal defence against claims its talc products cause cancer.

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

AZ starts work on Virginia plant in $50bn US investment plan

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

NHS could pay more for medicines under new plan

Regeneron's Libtayo stakes out new territory in skin cancer

J&J on the hook for $966m damages in latest talc lawsuit

Boehringer bags FDA okay for new pulmonary fibrosis drug

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks